NruI NEB#R0192

Restriction Enzymes NruI / Bsp68I

Experiment
Restriction Enzymes NruI / Bsp68I
Product
NruI NEB#R0192 from New England BioLabs
Manufacturer
New England BioLabs

Protocol tips

Protocol tips
For direct assembly of transformable plasmids by cycled ligation, a modified pUC19 vector (Table S1) with two blunt ligation sites separated by ∼250 bp was created. The vector was digested with NruI and SwaI (NEB) and the linearized vector was isolated and purified by gel extraction (Qiagen). Detailed protocol in Table S3.

Publication protocol

Both PCR products were treated with SacI and Aor51HI, and simultaneously cloned into the SacI site of the pFA6a-hphMX6 vector to obtain pSTk14. Next, a DNA fragment containing the full-length of the trt1+ gene was amplified using the following primer set.

Full paper   Login or join for free to view the full paper.

Reviews

NruI NEB#R0192 from New England BioLabs has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Restriction Enzymes NruI / Bsp68I using NruI NEB#R0192 from New England BioLabs.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from New England BioLabs for NruI NEB#R0192 below.

We haven't found the manufacturer protocol for this product yet.

Videos

Check out videos that might be relevant for performing Restriction Enzymes NruI / Bsp68I using NruI NEB#R0192 from New England BioLabs. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms